Title:
HETEROCYCLIC GUANIDINE F1F0-ATPASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2013/185048
Kind Code:
A3
Abstract:
The invention provides heterocyclic guanidine compounds that inhibit F1F0-ATPase, and methods of using heterocyclic guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Inventors:
HURD ALEXANDER R (US)
TAYLOR CLARKE B (US)
TOOGOOD PETER L (US)
TAYLOR CLARKE B (US)
TOOGOOD PETER L (US)
Application Number:
PCT/US2013/044738
Publication Date:
January 30, 2014
Filing Date:
June 07, 2013
Export Citation:
Assignee:
LYCERA CORP (US)
International Classes:
A61K31/155; A61P9/00; C07D231/00
Domestic Patent References:
| WO2010030891A2 | 2010-03-18 | |||
| WO2003050261A2 | 2003-06-19 |
Foreign References:
| US20040039033A1 | 2004-02-26 |
Other References:
See also references of EP 2866893A4
Attorney, Agent or Firm:
DAVIS, Chad, E. et al. (Exchange PlaceBoston, MA, US)
Download PDF:
Previous Patent: DIFFERENTIAL VCOM RESISTANCE OR CAPACITANCE TUNING FOR IMPROVED IMAGE QUALITY
Next Patent: OUTPUT LEVEL ADJUSTMENT DEVICE
Next Patent: OUTPUT LEVEL ADJUSTMENT DEVICE